Levodopa-4'-monophosphate Uses, Dosage, Side Effects and more
Levodopa-4'-monophosphate is under investigation in clinical trial NCT04750226 (Study to Assess Adverse Events and Change in Disease Activity of 24-hour Continuous Subcutaneous Infusion of ABBV-951 in Adult Participants With Advanced Parkinson's Disease).
| Trade Name | Levodopa-4'-monophosphate |
| Generic | Foslevodopa |
| Foslevodopa Other Names | 3-hydroxy-O-phosphono-L-tyrosine, Foslevodopa, Levodopa-4'-monophosphate |
| Type | |
| Formula | C9H12NO7P |
| Weight | Average: 277.169 Monoisotopic: 277.035138728 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
